Meta-analysis: prevalence of, and risk factors for, non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Mohammad ZamaniShaghayegh Alizadeh-TabariSiddharth SinghStephen CaldwellPublished in: Alimentary pharmacology & therapeutics (2022)
Up to one-third of patients with IBD experienced NAFLD worldwide. The risk of NAFLD was two times higher in IBD patients versus healthy subjects.